| Pharmaceutical active ingredients: |
| Hydromorphone Hydrochloride |
| Available forms, composition and doses of Dilaudid-XP: |
| Injectable; Injection; Hydromorphone Hydrochloride 50 mg / ml |
| Dilaudid-XP medical category: |
| Human:Opiate agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02AA03 - Hydromorphone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AbbottPurdue Pharma |
| Related documents and information about Dilaudid-XP: |
| Dilaudid prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Novolaudon | Hydromorphone | Unidentified Pharmaceutical Company |
| Paramorphan | Hydromorphone | Unidentified Pharmaceutical Company |
| Dilaudid | Hydromorphone Hydrochloride | Abbott; Purdue Pharma |
| Dilaudid-HP | Hydromorphone Hydrochloride | Abbott; Purdue Pharma |
| Dilaudid-HP-Plus | Hydromorphone Hydrochloride | Abbott; Purdue Pharma |
| Dolonovag | Hydromorphone Hydrochloride | Gobbi Novag Laboratorios |
| Exalgo | Hydromorphone Hydrochloride | Mallinckrodt; ALZA; Neuromed Pharmaceuticals |
| Hydal | Hydromorphone Hydrochloride | Mundipharma |
| Hydromorph | Hydromorphone Hydrochloride | Purdue Pharma |
| Hydromorph Contin | Hydromorphone Hydrochloride | Purdue Pharma |